Citation: Me. Peeples et Pl. Collins, Mutations in the 5 ' trailer region of a respiratory syncytial virus minigenome which limit RNA replication to one step, J VIROLOGY, 74(1), 2000, pp. 146-155
Authors:
Collins, PL
Moore, JJ
Lundgren, DW
Choobineh, E
Chang, SM
Chang, AS
Citation: Pl. Collins et al., Gestational changes in uterine L-type calcium channel function and expression in guinea pig, BIOL REPROD, 63(5), 2000, pp. 1262-1270
Authors:
Yunus, AS
Krishnamurthy, S
Pastey, MK
Huang, Z
Khattar, SK
Collins, PL
Samal, SK
Citation: As. Yunus et al., Rescue of a bovine respiratory syncytial virus genomic RNA analog by bovine, human and ovine respiratory syncytial viruses confirms the "functional integrity" and "cross-recognition'' of BRSV cis-acting elements by HRSV and ORSV, ARCH VIROL, 144(10), 1999, pp. 1977-1990
Authors:
Skiadopoulos, MH
Tao, T
Surman, SR
Collins, PL
Murphy, BR
Citation: Mh. Skiadopoulos et al., Generation of a parainfluenza virus type 1 vaccine candidate by replacing the HN and F glycoproteins of the live-attenuated PIV3 cp45 vaccine virus with their PIV1 counterparts, VACCINE, 18(5-6), 1999, pp. 503-510
Authors:
Tao, T
Skiadopoulos, MH
Durbin, AP
Davoodi, F
Collins, PL
Murphy, BR
Citation: T. Tao et al., A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challenge, VACCINE, 17(9-10), 1999, pp. 1100-1108
Authors:
Juhasz, K
Whitehead, SS
Boulanger, CA
Firestone, CY
Collins, PL
Murphy, BR
Citation: K. Juhasz et al., The two amino acid substitutions in the L protein of cpts530/1009, a live-attenuated respiratory syncytial virus candidate vaccine, are independent temperature-sensitive and attenuation mutations, VACCINE, 17(11-12), 1999, pp. 1416-1424
Authors:
Collins, PL
Whitehead, SS
Bukreyev, A
Fearns, R
Teng, MN
Juhasz, K
Chanock, RM
Murphy, BR
Citation: Pl. Collins et al., Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics, ADV VIRUS R, 54, 1999, pp. 423-451
Authors:
Durbin, AP
McAuliffe, JM
Collins, PL
Murphy, BR
Citation: Ap. Durbin et al., Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates, VIROLOGY, 261(2), 1999, pp. 319-330
Authors:
Skiadopoulos, MH
Surman, SR
St Claire, M
Elkins, WR
Collins, PL
Murphy, BR
Citation: Mh. Skiadopoulos et al., Attenuation of the recombinant human parainfluenza virus type 3 cp45 candidate vaccine virus is augmented by importation of the respiratory syncytialvirus cpts530 L polymerase mutation, VIROLOGY, 260(1), 1999, pp. 125-135
Citation: Pl. Collins et al., Support plasmids and support proteins required for recovery of recombinantrespiratory syncytial virus, VIROLOGY, 259(2), 1999, pp. 251-255
Authors:
Bukreyev, A
Whitehead, SS
Bukreyeva, N
Murphy, BR
Collins, PL
Citation: A. Bukreyev et al., Interferon gamma expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity, P NAS US, 96(5), 1999, pp. 2367-2372
Citation: A. Bermingham et Pl. Collins, The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription, P NAS US, 96(20), 1999, pp. 11259-11264
Citation: R. Fearns et Pl. Collins, Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription, J VIROLOGY, 73(7), 1999, pp. 5852-5864
Citation: K. Juhasz et al., The major attenuating mutations of the respiratory syncytial virus vaccinecandidate cpts530/1009 specify temperature-sensitive defects in transcription and replication and a non-temperature-sensitive alteration in mRNA termination, J VIROLOGY, 73(6), 1999, pp. 5176-5180
Authors:
Whitehead, SS
Bukreyev, A
Teng, MN
Firestone, CY
St Claire, M
Elkins, WR
Collins, PL
Murphy, BR
Citation: Ss. Whitehead et al., Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees, J VIROLOGY, 73(4), 1999, pp. 3438-3442
Authors:
Whitehead, SS
Firestone, CY
Karron, RA
Crowe, JE
Elkins, WR
Collins, PL
Murphy, BR
Citation: Ss. Whitehead et al., Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivity, J VIROLOGY, 73(2), 1999, pp. 871-877
Authors:
Skiadopoulos, MH
Surman, S
Tatem, JM
Paschalis, M
Wu, SL
Udem, SA
Durbin, AP
Collins, PL
Murphy, BR
Citation: Mh. Skiadopoulos et al., Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp45) human parainfluenza virus 3 candidate vaccine, J VIROLOGY, 73(2), 1999, pp. 1374-1381
Authors:
Whitehead, SS
Hill, MG
Firestone, CY
St Claire, M
Elkins, WR
Murphy, BR
Collins, PL
Citation: Ss. Whitehead et al., Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidates, J VIROLOGY, 73(12), 1999, pp. 9773-9780
Citation: R. Fearns et Pl. Collins, Model for polymerase access to the overlapped L gene of respiratory syncytial virus, J VIROLOGY, 73(1), 1999, pp. 388-397
Citation: Mn. Teng et Pl. Collins, Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein, J VIROLOGY, 73(1), 1999, pp. 466-473